SCHEMBL6187736

SCHEMBL6187736

COC1C=CC(C(=O)Nc2ccc3[nH]c(C)c(C(=O)c4c(Cl)cccc4Cl)c3c2)=CC1=S

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3G Q9HC16 1/20 0.36
MAPT P10636 7/20 0.34
RAB9A P51151 3/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 2/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
PTGES O14684 2/20 0.33
HPGD P15428 2/20 0.33
JAK2 O60674 2/20 0.33
JAK1 P23458 2/20 0.33
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.33
MAOB P27338 1/20 0.33
TYK2 P29597 1/20 0.32
ABL1 P00519 2/20 0.32
SRC P12931 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6187979 0.75 APOBEC3G (0.40) APOBEC3GMAPTHTTMAPK1KMT2A
SCHEMBL6188852 0.75 RAB9A (0.55) MAPTRAB9AHTTLMNATSHR
SCHEMBL6185825 0.75 TYK2 (0.45) MAPTRAB9AHTTLMNAKMT2A
SCHEMBL6491956 0.75 AKR1C3 (0.35) MAPTPTGESJAK2JAK1TYK2
SCHEMBL6189327 0.74 HPGD (0.46) MAPTHTTLMNAALOX15KMT2A
SCHEMBL6186285 0.72 MAOA (0.49) JAK2JAK1ALDH1A1MAOBTYK2
SCHEMBL6186843 0.71 ALDH1A1 (0.40) RAB9ATSHRALOX15KMT2AHPGD
SCHEMBL6185134 0.71 MAOA (0.54) LMNAHPGDJAK2ALDH1A1MAOB
SCHEMBL6185706 0.71 MAOB (0.42) MAPTRAB9AHTTLMNAMAPK1
SCHEMBL6188945 0.70 KMT2A (0.44) RAB9AHTTLMNATSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed